Vontobel Holding’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,053
Closed -$432K 1107
2022
Q4
$432K Buy
3,053
+792
+35% +$110K ﹤0.01% 795
2022
Q3
$317K Buy
2,261
+1,666
+280% +$305K ﹤0.01% 843
2022
Q2
$80K Buy
+595
New +$101K ﹤0.01% 989
2022
Q1
Sell
-480
Closed -$345K 1099
2021
Q4
$345K Buy
480
+32
+7% +$30.6K ﹤0.01% 897
2021
Q3
$495K Hold
448
﹤0.01% 797
2021
Q2
$659K Buy
448
+194
+76% +$269K 0.01% 689
2021
Q1
$401K Buy
254
+209
+464% +$490K ﹤0.01% 724
2020
Q4
$90K Buy
+45
New +$71.7K ﹤0.01% 935

Other funds holding LABU

Vontobel Holding's LABU Position: Q1 2023 in Review

Vontobel Holding sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2023, closing a stake of 3,053 shares — an estimated $432K sold.

Vontobel Holding first reported a position in LABU in Q4 2020 and held it in 8 quarters. The position peaked at $659K in Q2 2021. 57 funds tracked by Wall St. Rank hold LABU as of Q1 2023.

  • Vontobel Holding reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2023 after selling out during the quarter.
  • Vontobel Holding sold 3,053 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2023, an estimated $432K.
  • Vontobel Holding first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2020 and held it in 8 quarters.
  • Vontobel Holding's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $659K in Q2 2021.
  • 57 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2023.

Based on Vontobel Holding's 13F filing for Q1 2023, filed 12 Apr 2023.